GlassScriptPhysician profile
Bruce M Coull
NPI 1629041942
$381.00
in general payments reported to CMS, 2019-2025
13 companies · $75.08 in 2025
The $75.08 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.68 · 2020: $187 · 2022: $52.60 · 2023: $13.29 · 2025: $75.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $92.43 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $43.67 | 2022-2025 | |
| Biogen, INC. | $36.41 | 2019-2025 | Vumerity, Tysabri |
| Amgen INC. | $34.44 | 2020 | |
| Allergan, INC. | $32.22 | 2020 | |
| Ucb, INC. | $21.04 | 2020 | |
| Lilly USA, LLC | $19.90 | 2020 | |
| Kyowa Kirin, INC. | $18.80 | 2019 | |
| Genentech USA, INC. | $18.25 | 2019 | |
| Genzyme Corporation | $18.10 | 2020 | |
| Emd Serono, INC. | $16.08 | 2020 | |
| Amneal Pharmaceuticals LLC | $15.15 | 2020 | |
| Assertio Therapeutics, INC. | $14.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Coull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.